Jhala Nilyum 4

What Happened Jhala Nilyum, Chief Technology Officer of Trulieve Cannabis Corp. (TRUL), received two awards on March 13, 2026: 58,594 restricted stock units (RSUs) and 41,668 derivative awards (options/option-like awards). Both grants were reported at $0.00 per share (awards, not purchases), so no cash changed hands. These are compensation awards rather than open-market buys or sales.

Key Details

• Transaction date and price: March 13, 2026; both reported at $0.00 per share (grant/award codes: A).
• Award amounts: 58,594 RSUs + 41,668 derivative awards = 100,262 total units granted.
• Shares owned after transaction: Not specified in the filing.
• Vesting/exercise terms (from footnotes):
  • F1 (RSUs): Each RSU converts to one share when vested; 50% of the RSUs vest on Dec 1, 2027 and the remaining 50% on Dec 1, 2028.
  • F2 (derivative award): Becomes exercisable in three annual installments — one-third on Dec 1, 2026, one-third on Dec 1, 2027, and one-third on Dec 1, 2028.
• Filing timeliness: Report filed on March 17, 2026 (covers March 13 transaction); filing shows no late-filing flag.

Context RSUs are a contingent right to receive shares only after vesting, and the derivative award here is subject to a multi-year vesting/exercisability schedule — neither results in immediate free-tradable shares. These awards are typical executive compensation and do not by themselves indicate a buy or sell signal; they represent future potential ownership if vesting/exercise conditions are met.